Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MASCC/ISOO expert opinion on the management of oral problems in patients with advanced cancer.
Jones JA, Chavarri-Guerra Y, Corrêa LBC, Dean DR, Epstein JB, Fregnani ER, Lee J, Matsuda Y, Mercadante V, Monsen RE, Rajimakers NJH, Saunders D, Soto-Perez-de-Celis E, Sousa MS, Tonkaboni A, Vissink A, Yeoh KS, Davies AN. Jones JA, et al. Among authors: mercadante v. Support Care Cancer. 2022 Nov;30(11):8761-8773. doi: 10.1007/s00520-022-07211-2. Epub 2022 Jun 18. Support Care Cancer. 2022. PMID: 35717462 Free PMC article.
Questionable validity of the systematic review and meta-analysis by Lovelace et al. on management of radiotherapy-induced salivary hypofunction and xerostomia in patients with oral or head and neck cancer.
Mercadante V, Lodi G, Porter S, Fedele S. Mercadante V, et al. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Jan;119(1):120-1. doi: 10.1016/j.oooo.2014.07.538. Epub 2014 Sep 30. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015. PMID: 25482550 Free article. No abstract available.
Salivary Electrostimulation in the Treatment of Radiation Therapy-Induced Xerostomia (LEONIDAS-2): A Multicenter, Randomized, Double-Masked, Sham-Controlled, Phase 3 Trial.
Mercadante V, Hamad AA, McCaul J, Nutting C, Harrington K, Carnell D, Urbano TG, Kalavrezos N, Barber JA, Porter SR, Fedele S. Mercadante V, et al. Int J Radiat Oncol Biol Phys. 2024 Jan 1;118(1):142-153. doi: 10.1016/j.ijrobp.2023.03.047. Epub 2023 Mar 17. Int J Radiat Oncol Biol Phys. 2024. PMID: 36933846 Clinical Trial.
Oral medicine: off-label cream use.
Porter S, Mercadante V, Fedele S. Porter S, et al. Among authors: mercadante v. Br Dent J. 2014 Dec;217(12):660-1. doi: 10.1038/sj.bdj.2014.1107. Br Dent J. 2014. PMID: 25524996 No abstract available.
Comments on "diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus".
Otto S, Marx RE, Tröltzsch M, Ristow O, Ziebart T, Al-Nawas B, Groetz KA, Ehrenfeld M, Mercadante V, Porter S, Bedogni A, Campisi G, Fusco V, Dayisoylu E, Fliefel R, Herlofson BB, Pautke C, Kwon TG, Fedele S. Otto S, et al. Among authors: mercadante v. J Bone Miner Res. 2015 Jun;30(6):1113-5. doi: 10.1002/jbmr.2525. J Bone Miner Res. 2015. PMID: 25988662 Free article. No abstract available.
Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study.
Fung P, Bedogni G, Bedogni A, Petrie A, Porter S, Campisi G, Bagan J, Fusco V, Saia G, Acham S, Musto P, Petrucci MT, Diz P, Colella G, Mignogna MD, Pentenero M, Arduino P, Lodi G, Maiorana C, Manfredi M, Hallberg P, Wadelius M, Takaoka K, Leung YY, Bonacina R, Schiødt M, Lakatos P, Taylor T, De Riu G, Favini G, Rogers SN, Pirmohamed M, Nicoletti P; GENVABO Consortium; Fedele S. Fung P, et al. Oral Dis. 2017 May;23(4):477-483. doi: 10.1111/odi.12632. Epub 2017 Mar 6. Oral Dis. 2017. PMID: 28039941 Free article.
81 results